Role of MicroRNA mi R-33 in Controlling Cholesterol/Lipid Homeostasis

MicroRNA miR-33 在控制胆固醇/脂质稳态中的作用

基本信息

  • 批准号:
    7708682
  • 负责人:
  • 金额:
    $ 22.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-08-05 至 2011-07-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The sterol response element binding protein (SREBP) transcription factors have been identified as key regulators of genes involved in both cholesterol and lipid homeostasis. Because of the prominence of aberrant cholesterol and lipid homeostasis in the metabolic dysregulation underpinning cardiovascular disease and diabetes, transcriptional regulators of cholesterol/lipids such as SREBPs could potentially represent important therapeutic targets to ameliorate these diseases. Interestingly, small regulatory RNAs termed microRNAs (miRNAs) have recently also been found to represent important regulators of eukaryotic gene expression. One miRNA, miR-122, was shown in recent studies to modulate cholesterol levels in mice and non-human primates. These studies have highlighted the critical role played by miRNAs in mammalian physiology with relevance to human health. Intriguingly, we have obtained preliminary data suggesting that miR-33a/b, miRNAs that are embedded within intronic sequences in both SREBP-1 and -2 genes in humans, regulate cholesterol homeostasis in mammals in coordination with the SREBP host gene products. Our results show that miR-33 miRNAs target the ABCA1 cholesterol transporter for translational repression, resulting in lowered ABCA1 protein levels and decreased cholesterol efflux. As SREBPs promote cholesterol uptake and synthesis through the transactivation of the LDL receptor gene and cholesterol biosynthesis genes, inhibition of cholesterol efflux by miR-33-dependent down-regulation of ABCA1 acts in cooperation with SREBPs to effectively boost intracellular cholesterol levels. We propose a series of in vitro and in vivo studies to further determine the functional role of miR-33 in controlling cholesterol and lipid homeostasis in cooperation with SREBPs. These studies could have important ramifications for our understanding of the integration and coordination of miRNA and transcription factor gene regulation and will facilitate novel therapeutic strategies to increase HDL synthesis and reverse cholesterol transport in patients with cardiovascular disease. The Specific Aims are: 1. To examine the co-expression of miR-33 and its host gene SREBP in cells and tissues. 2. To determine the role of miR-33 in regulation of cholesterol trafficking. PUBLIC HEALTH RELEVANCE: Cholesterol and fatty acids play critical functional roles in many physiological processes in metazoans, such as modulating membrane fluidity, serving as signaling molecules, and providing energy storage in the form of triglycerides. Abnormal cholesterol and lipid levels have been linked to increasingly prevalent diseases, including atherosclerosis, obesity, type II diabetes, and hypertension (all associated with metabolic syndrome), as well as lipodystrophy, Alzheimers Disease, and certain cancers, underscoring the importance of understanding fully how cholesterol and lipid homeostasis are regulated and maintained. We and others have investigated cholesterol and lipids are controlled by gene switches termed sterol regulatory element binding protein (SREBP). Intriguingly, we have noted the presence of microRNAs (miR- 33a/b) within intronic sequences in the human SREBP-2 and -1 genes, respectively. Preliminary studies yielded the surprising finding that miR-33a/b appear to repress the cholesterol transporter ABCA1, a key regulator of HDL synthesis that is involved in preventing atherosclerosis. As SREBPs promote cholesterol uptake and synthesis, we predict that miR-33-mediated inhibition of ABCA1 and cholesterol efflux acts in cooperation with SREBPs to boost intracellular cholesterol levels. We propose a series of in vitro and in vivo studies that will delineate the role of miR-33 in controlling cholesterol/lipid homeostasis in cooperation with SREBPs. These studies should provide novel therapeutic strategies aimed at increasing HDL synthesis and cholesterol clearance in patients with cardiovascular disease.
描述(由申请人提供):甾醇反应元件结合蛋白(SREBP)转录因子已被确定为参与胆固醇和脂质稳态的基因的关键调节因子。由于异常的胆固醇和脂质稳态在心血管疾病和糖尿病的代谢失调中表现突出,胆固醇/脂质的转录调节因子如SREBPs可能是改善这些疾病的重要治疗靶点。有趣的是,被称为microRNAs (miRNAs)的小调控rna最近也被发现是真核生物基因表达的重要调控因子。最近的研究显示,一种名为miR-122的miRNA可以调节小鼠和非人灵长类动物的胆固醇水平。这些研究强调了mirna在哺乳动物生理学中与人类健康相关的关键作用。有趣的是,我们已经获得的初步数据表明,miR-33a/b,嵌入在人类SREBP-1和-2基因的内含子序列中的mirna,与SREBP宿主基因产物协同调节哺乳动物的胆固醇稳态。我们的研究结果表明,miR-33 mirna靶向ABCA1胆固醇转运蛋白进行翻译抑制,导致ABCA1蛋白水平降低,胆固醇外排减少。SREBPs通过反激活LDL受体基因和胆固醇生物合成基因促进胆固醇摄取和合成,通过mir -33依赖性下调ABCA1抑制胆固醇外排,与SREBPs协同作用,有效提高细胞内胆固醇水平。我们提出了一系列体外和体内研究,以进一步确定miR-33在与SREBPs合作控制胆固醇和脂质稳态中的功能作用。这些研究可能对我们理解miRNA和转录因子基因调控的整合和协调有重要的影响,并将促进新的治疗策略,以增加心血管疾病患者的HDL合成和逆转胆固醇转运。具体目标是:1。检测miR-33及其宿主基因SREBP在细胞和组织中的共表达。2. 确定miR-33在调节胆固醇转运中的作用。公共卫生相关性:胆固醇和脂肪酸在后生动物的许多生理过程中发挥着关键的功能作用,如调节膜流动性,作为信号分子,并以甘油三酯的形式提供能量储存。异常的胆固醇和脂质水平与越来越普遍的疾病有关,包括动脉粥样硬化、肥胖、II型糖尿病和高血压(都与代谢综合征有关),以及脂质营养不良、阿尔茨海默病和某些癌症,这强调了充分了解胆固醇和脂质平衡是如何调节和维持的重要性。我们和其他人已经研究了胆固醇和脂质是由称为甾醇调节元件结合蛋白(SREBP)的基因开关控制的。有趣的是,我们注意到在人类SREBP-2和-1基因的内含子序列中分别存在microrna (miR- 33a/b)。初步研究得出了令人惊讶的发现,miR-33a/b似乎抑制胆固醇转运体ABCA1, ABCA1是HDL合成的关键调节因子,参与预防动脉粥样硬化。由于SREBPs促进胆固醇摄取和合成,我们预测mir -33介导的ABCA1抑制和胆固醇外排与SREBPs合作,提高细胞内胆固醇水平。我们提出了一系列体外和体内研究,以描述miR-33在与SREBPs合作控制胆固醇/脂质稳态中的作用。这些研究应该提供新的治疗策略,旨在增加心血管疾病患者的HDL合成和胆固醇清除。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANDERS M NAAR其他文献

ANDERS M NAAR的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANDERS M NAAR', 18)}}的其他基金

The mechanistic role of metabolic gene MTCH2/mtch-1 in lipid homeostasis, longevity, and fertility
代谢基因 MTCH2/mtch-1 在脂质稳态、长寿和生育能力中的机制作用
  • 批准号:
    10417062
  • 财政年份:
    2019
  • 资助金额:
    $ 22.1万
  • 项目类别:
The mechanistic role of metabolic gene MTCH2/mtch-1 in lipid homeostasis, longevity, and fertility
代谢基因 MTCH2/mtch-1 在脂质稳态、长寿和生育能力中的机制作用
  • 批准号:
    10179267
  • 财政年份:
    2019
  • 资助金额:
    $ 22.1万
  • 项目类别:
The mechanistic role of metabolic gene MTCH2/mtch-1 in lipid homeostasis, longevity, and fertility
代谢基因 MTCH2/mtch-1 在脂质稳态、长寿和生育能力中的机制作用
  • 批准号:
    10650721
  • 财政年份:
    2019
  • 资助金额:
    $ 22.1万
  • 项目类别:
A thrifty microRNA in insulin resistance and Type 2 diabetes
胰岛素抵抗和 2 型糖尿病中节俭的 microRNA
  • 批准号:
    9364401
  • 财政年份:
    2017
  • 资助金额:
    $ 22.1万
  • 项目类别:
Regulation of cholesterol/lipid homeostasis by microRNA-33a/b
microRNA-33a/b 调节胆固醇/脂质稳态
  • 批准号:
    8856224
  • 财政年份:
    2011
  • 资助金额:
    $ 22.1万
  • 项目类别:
Regulation of cholesterol/lipid homeostasis by microRNA-33a/b
microRNA-33a/b 调节胆固醇/脂质稳态
  • 批准号:
    8221853
  • 财政年份:
    2011
  • 资助金额:
    $ 22.1万
  • 项目类别:
Regulation of cholesterol/lipid homeostasis by microRNA-33a/b
microRNA-33a/b 调节胆固醇/脂质稳态
  • 批准号:
    8685255
  • 财政年份:
    2011
  • 资助金额:
    $ 22.1万
  • 项目类别:
Regulation of cholesterol/lipid homeostasis by microRNA-33a/b
microRNA-33a/b 调节胆固醇/脂质稳态
  • 批准号:
    8337383
  • 财政年份:
    2011
  • 资助金额:
    $ 22.1万
  • 项目类别:
Regulation of cholesterol/lipid homeostasis by microRNA-33a/b
microRNA-33a/b 调节胆固醇/脂质稳态
  • 批准号:
    8501444
  • 财政年份:
    2011
  • 资助金额:
    $ 22.1万
  • 项目类别:
Role of MicroRNA mi R-33 in Controlling Cholesterol/Lipid Homeostasis
MicroRNA miR-33 在控制胆固醇/脂质稳态中的作用
  • 批准号:
    7905935
  • 财政年份:
    2009
  • 资助金额:
    $ 22.1万
  • 项目类别:

相似海外基金

ATP Binding Cassette Transporters in Health and Disease
健康和疾病中的 ATP 结合盒转运蛋白
  • 批准号:
    10390366
  • 财政年份:
    2021
  • 资助金额:
    $ 22.1万
  • 项目类别:
ATP Binding Cassette Transporters in Health and Disease
健康和疾病中的 ATP 结合盒转运蛋白
  • 批准号:
    10237095
  • 财政年份:
    2021
  • 资助金额:
    $ 22.1万
  • 项目类别:
ATP Binding Cassette Transporters in Health and Disease
健康和疾病中的 ATP 结合盒转运蛋白
  • 批准号:
    10552563
  • 财政年份:
    2021
  • 资助金额:
    $ 22.1万
  • 项目类别:
Photosensitizing Nanoconstructs for Regulation of ATP-Binding Cassette Transporters in the Brain
用于调节大脑中 ATP 结合盒转运蛋白的光敏纳米结构
  • 批准号:
    2030253
  • 财政年份:
    2020
  • 资助金额:
    $ 22.1万
  • 项目类别:
    Standard Grant
Structural and functional studies of iron uptake ATP-binding cassette transporters (ABC transporters) in Gram-negative bacteria
革兰氏阴性菌中铁摄取 ATP 结合盒转运蛋白(ABC 转运蛋白)的结构和功能研究
  • 批准号:
    20K22561
  • 财政年份:
    2020
  • 资助金额:
    $ 22.1万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Investigating the mechanism of polysaccharide recognition and export by bacterial ATP-binding cassette transporters
研究细菌 ATP 结合盒转运蛋白识别和输出多糖的机制
  • 批准号:
    489384-2016
  • 财政年份:
    2018
  • 资助金额:
    $ 22.1万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Investigating the mechanism of polysaccharide recognition and export by bacterial ATP-binding cassette transporters
研究细菌 ATP 结合盒转运蛋白识别和输出多糖的机制
  • 批准号:
    489384-2016
  • 财政年份:
    2017
  • 资助金额:
    $ 22.1万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Investigating the mechanism of polysaccharide recognition and export by bacterial ATP-binding cassette transporters
研究细菌 ATP 结合盒转运蛋白识别和输出多糖的机制
  • 批准号:
    489384-2016
  • 财政年份:
    2016
  • 资助金额:
    $ 22.1万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
The Mechanism of ATP Binding Cassette Transporters
ATP 结合盒转运蛋白的机制
  • 批准号:
    318360
  • 财政年份:
    2014
  • 资助金额:
    $ 22.1万
  • 项目类别:
    Fellowship Programs
Heat shock protein 27 attenuates foam cell formation by enhancing cholesterol efflux via the ATP-binding cassette transporters A1
热休克蛋白 27 通过 ATP 结合盒转运蛋白 A1 增强胆固醇流出,从而减弱泡沫细胞形成
  • 批准号:
    304334
  • 财政年份:
    2014
  • 资助金额:
    $ 22.1万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了